site stats

Gynecol. oncol

WebApr 14, 2024 · Covariates. We reviewed our prospectively maintained institutional gynecological cancer database for demographic characteristics (age, height, and weight), clinical characteristics (treatment methods, FIGO stage, histological type and grade, residual disease status, and malignant ascites), Eastern Cooperative Oncology Group (ECOG) … WebLate-Breaking Abstract 5: Results from a 2nd interim OS analysis in OCEANS: A randomized phase 3 trial of gemcitabine (G), carboplatin (C) and bevacizumab (BV) followed by BV to disease progression in patients with platinum-sensitive recurrent epithelial ovarian (OC), primary peritoneal (PPC), or fallopian tube cancer (FTC) C. Aghajanian, S ...

Adjuvant Chemotherapy plus Radiation for Locally Advanced …

WebMay 27, 2024 · Gynecologic Oncology has an h-index of 173.It means 173 articles of this journal have more than 173 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been … WebObjective: Categorization and risk stratification of endometrial carcinomas is inadequate; histomorphologic assessment shows considerable interobserver variability, and risk of metastases and recurrence can only be derived after surgical staging. We have developed a Proactive Molecular Risk classification tool for Endometrial cancers (ProMisE) that … chesterfield hotel with hot tub https://xlaconcept.com

A phase II trial of radiation therapy and weekly cisplatin ... - PubMed

WebAffiliations 1 Department of Obstetrics and Gynecology, Massachusetts General Hospital, United States of America. Electronic address: [email protected]. 2 Division of Gynecologic Oncology, Rush University Medical Center, Chicago, IL, United States of America.; 3 Kelly Gynecologic Oncology Service, Department of Gynecology and … WebMajor clinical research advances in gynecologic cancer in 2024: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3. Lee JY, Lee YY, Park JY, Shim SH, Kim SI, … WebGynecologic oncology is a specialized field of medicine that focuses on treatment for cancers of the ovaries, vagina, uterus, cervix, and vulva. A gynecologic oncologist cares … chesterfield hotel west palm beach florida

Gynecologic Oncology Impact Factor IF 2024 2024 2024 - BioxBio

Category:Gynecologic Oncology Journal ScienceDirect.com by …

Tags:Gynecol. oncol

Gynecol. oncol

Gynecologic Oncology All Journal Issues - ScienceDirect

WebObjective: The efficacy and safety of olaparib, an oral poly(ADP-ribose) polymerase (PARP) inhibitor, was investigated in a subgroup of patients with germline BRCA1/2 mutated (gBRCA1/2m) advanced ovarian cancer who had received ≥3 prior lines of chemotherapy. Primary data from this Phase II study (Study 42, ClinicalTrials.govNCT01078662) have … WebAbout Gynecologic Oncology. Approximately 80,000 women in the United States are diagnosed annually with some form of gynecologic cancer – Gynecologic Oncologists …

Gynecol. oncol

Did you know?

WebDec 25, 2024 · Systemic therapies for cervical cancer are given by a gynecologic oncologist or medical oncologist, doctors who specialize in treating cancer with medication. … WebGynecologic Oncology Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 0090-8258. ... Journal Impact. Enter journal title, issn or abbr in this box to search. Gynecologic Oncology. Journal Abbreviation: GYNECOL ONCOL Journal ISSN: 0090-8258. Year: Impact Factor (IF) Total Articles: Total Cites: 2024 (2024 ...

WebA phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. … WebGynecologic Oncology, an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. Investigations …

WebDec 21, 2024 · Affiliations 1 Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: [email protected]. 2 Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.; 3 Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan.; 4 Department of Oncology, … WebGynecologic Oncology, an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. Investigations … Latest issue - Gynecologic Oncology Journal ScienceDirect.com by Elsevier All issues - Gynecologic Oncology Journal ScienceDirect.com by Elsevier Note to users:. Articles in press are peer reviewed, accepted articles to be … Special issues and article collections - Gynecologic Oncology Journal … View Full Editorial Board - Gynecologic Oncology Journal ScienceDirect.com … View All News - Gynecologic Oncology Journal ScienceDirect.com by Elsevier

WebA phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group …

WebGynecol Oncol. 2014;132(3):618–623. 28. Sakuragi N. Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer. Int J Clin Oncol. 2007;12(3):165–175. 29. Zhou J, Ran J, He ZY, et al. Tailoring pelvic lymphadenectomy for patients with stage IA2, IB1, and IIA1 uterine cervical cancer. goodnight gorilla children\u0027s bookWebRachel Ruskin, M.D. Associate Clinical Professor, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology. Print PDF. Save contact. To see if Rachel Ruskin is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284). Gynecology Oncology. chesterfield hotel west palm beachWebObjective: Indoleamine 2,3-dioxygenase-1 (IDO1) is a key regulator of immune tolerance in ovarian cancer. This study investigated efficacy and safety of the IDO1 enzyme inhibitor epacadostat versus tamoxifen in patients with biochemical-only recurrence (CA-125 elevation) following complete remission after first-line chemotherapy for advanced … goodnight gorilla book publisher